Xtant Medical Holdings (XTNT) Gains from Sales and Divestitures (2020 - 2025)
Xtant Medical Holdings (XTNT) reported Gains from Sales and Divestitures of $1.2 million for Q3 2025, down 22.08% year-over-year from $1.5 million in Q3 2024, and up 198.69% on a QoQ basis from $386624.0 in Q2 2025.
Xtant Medical Holdings (XTNT) has 6 years of Gains from Sales and Divestitures data on file, last reported at $1.2 million in Q3 2025.
- Quarterly Gains from Sales and Divestitures fell 22.08% year-over-year to $1.2 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $1.2 million (down 22.08% YoY) and the FY2024 annual result came in at $1.3 million, down 14.67% from the prior year.
- Gains from Sales and Divestitures advanced to $1.2 million in Q3 2025 per XTNT's latest filing, from $386624.0 in the prior quarter.
- Across five years, Gains from Sales and Divestitures topped out at $1.5 million in Q4 2023 and bottomed at $22245.0 in Q1 2023.
- The 5-year median for Gains from Sales and Divestitures is $349572.0 (2021), against an average of $611811.6.
- The widest annual swing landed in 2023, when Gains from Sales and Divestitures slumped 90.91%; it then soared 539.82% in 2024.
- Tracing XTNT's Gains from Sales and Divestitures over 5 years: stood at $782596.0 in 2021, then surged by 91.72% to $1.5 million in 2022, then gained by 2.39% to $1.5 million in 2023, then declined by 14.67% to $1.3 million in 2024, then slipped by 11.91% to $1.2 million in 2025.
- Per Business Quant, the three latest XTNT Gains from Sales and Divestitures figures stand at $1.2 million (Q3 2025), $386624.0 (Q2 2025), and $44496.0 (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Xtant Medical Holdings | 64.46 Mn | 47.14 Mn | 17.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1.15 Mn |
| Sep 30, 2025 | 1.15 Mn |
| Jun 30, 2025 | 386,624.00 |
| Jun 30, 2025 | 386,624.00 |
| Mar 31, 2025 | 44,496.00 |
| Mar 31, 2025 | 44,496.00 |
| Dec 31, 2024 | 1.31 Mn |
| Dec 31, 2024 | 1.31 Mn |
| Sep 30, 2024 | 1.48 Mn |
| Sep 30, 2024 | 1.48 Mn |
| Jun 30, 2024 | 142,327.00 |
| Jun 30, 2024 | 142,327.00 |
| Mar 31, 2024 | 44,496.00 |
| Mar 31, 2024 | 44,496.00 |
| Dec 31, 2023 | 1.54 Mn |
| Dec 31, 2023 | 1.54 Mn |
| Sep 30, 2023 | 1.01 Mn |
| Sep 30, 2023 | 1.01 Mn |
| Jun 30, 2023 | 22,245.00 |
| Jun 30, 2023 | 22,245.00 |
| Mar 31, 2023 | 22,245.00 |
| Mar 31, 2023 | 22,245.00 |
| Dec 31, 2022 | 1.50 Mn |
| Dec 31, 2022 | 1.50 Mn |
| Sep 30, 2022 | 851,955.00 |
| Sep 30, 2022 | 851,955.00 |
| Jun 30, 2022 | 244,721.00 |
| Jun 30, 2022 | 244,721.00 |
| Mar 31, 2022 | 244,721.00 |
| Mar 31, 2022 | 244,721.00 |
| Dec 31, 2021 | 782,596.00 |
| Dec 31, 2021 | 782,596.00 |
| Sep 30, 2021 | 349,572.00 |
| Sep 30, 2021 | 349,572.00 |
| Jun 30, 2021 | 244,716.00 |
| Jun 30, 2021 | 244,716.00 |
| Mar 31, 2021 | 244,716.00 |
| Mar 31, 2021 | 244,716.00 |
| Dec 31, 2020 | 144,878.00 |
| Dec 31, 2020 | 144,878.00 |
| Sep 30, 2020 | 79,069.00 |
| Sep 30, 2020 | 79,069.00 |
| Jun 30, 2020 | 61,803.00 |
| Jun 30, 2020 | 61,803.00 |
| Mar 31, 2020 | 61,803.00 |
| Mar 31, 2020 | 61,803.00 |